RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

Medical devices and methods

  • US 10,136,816 B2
  • Filed: 08/31/2010
  • Issued: 11/27/2018
  • Est. Priority Date: 08/31/2009
  • Status: Active Grant
  • ×

    Create Patent Alert


    *Certain alert events are not available for your current subscription level. Upgrade
  • Save